MoonLake Immunotherapeutics (MLTX) Interest Coverage Ratio (2021 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly Interest Coverage Ratio came in at 30.45 in Q1 2026, up 76.41% year-on-year from 17.26 in Q1 2025, and down 111.25% quarter-over-quarter from 270.61 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 30.45 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 76.41% year-over-year to 30.45 in Q1 2026; TTM through Mar 2026 was 47.53, a 67.67% increase from a year earlier, with the FY2025 full-year figure at 33.78, down 488.57% from the prior year.
- Interest Coverage Ratio declined to 30.45 in Q1 2026 per MLTX's latest filing, from 270.61 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 270.61 in Q4 2025 and bottomed at 24265.32 in Q1 2022.
- The 5-year median for Interest Coverage Ratio is 86.9 (2023), against an average of 1576.56.
- Across the five-year window, Interest Coverage Ratio slumped 5296.03% in 2022 and soared 240.06% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 494.61 in 2022, then jumped by 82.43% to 86.9 in 2023, then sank by 122.34% to 193.21 in 2024, then surged by 240.06% to 270.61 in 2025, then slumped by 111.25% to 30.45 in 2026.
- Per Business Quant, the three latest MLTX Interest Coverage Ratio figures stand at 30.45 (Q1 2026), 270.61 (Q4 2025), and 22.34 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | MoonLake Immunotherapeutics | 1.38 Bn | 1.02 Bn | - | -30.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.45 |
| Dec 31, 2025 | 270.61 |
| Sep 30, 2025 | -22.34 |
| Jun 30, 2025 | -2.37 |
| Mar 31, 2025 | -129.04 |
| Dec 31, 2024 | -193.21 |
| Sep 30, 2024 | -12.05 |
| Jun 30, 2024 | -147.67 |
| Mar 31, 2024 | -54.45 |
| Dec 31, 2023 | -86.90 |
| Sep 30, 2023 | -76.24 |
| Jun 30, 2023 | -62.08 |
| Mar 31, 2023 | -333.07 |
| Dec 31, 2022 | -494.61 |
| Sep 30, 2022 | -908.23 |
| Jun 30, 2022 | -254.06 |
| Mar 31, 2022 | -24,265.32 |
| Dec 31, 2021 | -9.17 |